Brevan Howard Capital Management »

Peregrine Pharmaceuticals shares owned by Brevan Howard Capital Management

Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Brevan Howard Capital Management from 13F filings

Historical chart of Brevan Howard Capital Management investment in Peregrine Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Peregrine Pharmaceuticals held by Brevan Howard Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Peregrine Pharmaceuticals by Brevan Howard Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $112k 17k 6.50

More positions owned by Brevan Howard Capital Management

Ishares Msci Emerging Mkt In Msci Emg Mkt Etf (EEM)
Financial Select Sector Spdr Financial Call Option
Invesco QQQ Trust Series 1 Nasdaq100 BB:QQQ Unit Ser 1 (QQQ)
Ishares Iboxx H/y Corp Bond Iboxx Hi Yd Etf (HYG)
Consumer Staples Spdr Sbi Cons Stpls (XLP)
Ishares Russell 2000 Etf Russell 2000 Etf (IWM)
Health Care Select Secto Sbi Healthcare Call Option (XLV)
Ishares Jp Morgan Usd Emerging Markets Jpmorgan Ud Emg (EMB)
ISHARES 20plus YR TREAS 20 Yr Tr Bd Etf Call Option (TLT)
KraneShares CSI China Internet ETF Csi Chi Internet (KWEB)
Ishares Ftse/xinhua China 25 China Lg-cap Etf (FXI)
Ishares Msci Eafe Index Fund Msci Eafe Etf Put Option (EFA)
Ishares Msci Brazil Msci Brazil Etf (EWZ)
Kbw Regional Banking Etf S&p Regl Bkg Call Option (KRE)
Vnet 0 02/26 Note 2/0 (Principal)

View all positions for Brevan Howard Capital Management

Top funds holding Peregrine Pharmaceuticals

Millennium Management
Vanguard Group
AltraVue Capital
Royal Bank of Canada
Palisade Capital Management
Wellington Management Company
Punch & Associates Investment Management
AWM Investment Company
Kornitzer Capital Management
New York State Common Retirement Fund
Dimensional Fund Advisors
Sargent Investment Group
Goldman Sachs Group
B. Riley Asset Management
Two Sigma Investments

View all funds holding Peregrine Pharmaceuticals